GEN’s Jonathan Grinstein, PhD, and Alex Philippidis discuss Day 2 of the J.P. Morgan 41st Healthcare Conference being held in San Francisco, focusing on the executives and investment leaders they interviewed. Among investment leaders were Vijay Pande, PhD, of Andreessen Horowitz (a16z); Samir Kaul of Khosla Ventures; and Tom Burt, EngD of Soffinova Partners. Jonathan and Alex also discuss the companies whose leaders they also interviewed, including Alto Neuroscience, Bayer Oncology, and Vor Bio.

ConferencesHealth care and economicsHealth care economicsHealth care facility, manpower, and servicesHealth care investmentProfessional and career developmentResearch and developmentResearch resourcesAlto NeuroscienceAndreessen HorowitzKhosla VenturesSofinnova PartnersVor Bio
Previous articleUncovering the Link between Obesity and Diabetes Risk
Next articleReporter’s Notebook: On Day 2 of J.P. Morgan, Start-Ups Soliciting Cash and VCs Eschewing High Risk
Also of Interest
Novel Approach Restores Brain Function after Stroke-Like Injury in Mice
Genomes Reveal the Encounter between Neanderthals and Sapiens
Accelerating Drug Development Using Medical Imaging AI
Commensal E. coli in Gut Readily Displaced by Drug-Resistant E. coli
Curbing Lung Cancer Metastasis with Nanoparticle Vaccine
Increasing Access to Cell Therapies
Related Media
Nobel Winner Katalin Karikó Shared mRNA Vaccine Story with GEN, Mid-Pandemic
Boston and Bioprocessing: GEN Reports Live from the First Day at BPI
Excitement in Oakland: A Report from SynBioBeta
Carl Icahn States His Case for Change at Illumina on “Close to the Edge”
Celebrating DNA: Matthew Cobb’s Reflections on the Double Helix
Emerging Markets Collaborate to Succeed in Post-Pandemic World